These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 18593902)
1. 15-Hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3beta and a tumor suppressor in lung cancer. Huang G; Eisenberg R; Yan M; Monti S; Lawrence E; Fu P; Walbroehl J; Löwenberg E; Golub T; Merchan J; Tenen DG; Markowitz SD; Halmos B Cancer Res; 2008 Jul; 68(13):5040-8. PubMed ID: 18593902 [TBL] [Abstract][Full Text] [Related]
2. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer. Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386 [TBL] [Abstract][Full Text] [Related]
3. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer. Hughes D; Otani T; Yang P; Newman RA; Yantiss RK; Altorki NK; Port JL; Yan M; Markowitz SD; Mazumdar M; Tai HH; Subbaramaiah K; Dannenberg AJ Cancer Prev Res (Phila); 2008 Sep; 1(4):241-9. PubMed ID: 19138967 [TBL] [Abstract][Full Text] [Related]
4. 15-Hydroxyprostaglandin dehydrogenase is a tumor suppressor of human gastric cancer. Liu Z; Wang X; Lu Y; Du R; Luo G; Wang J; Zhai H; Zhang F; Wen Q; Wu K; Fan D Cancer Biol Ther; 2010 Oct; 10(8):780-7. PubMed ID: 20699658 [TBL] [Abstract][Full Text] [Related]
5. Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression. Kaliberova LN; Kusmartsev SA; Krendelchtchikova V; Stockard CR; Grizzle WE; Buchsbaum DJ; Kaliberov SA Mol Cancer Ther; 2009 Nov; 8(11):3130-9. PubMed ID: 19887544 [TBL] [Abstract][Full Text] [Related]
6. 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis. Myung SJ; Rerko RM; Yan M; Platzer P; Guda K; Dotson A; Lawrence E; Dannenberg AJ; Lovgren AK; Luo G; Pretlow TP; Newman RA; Willis J; Dawson D; Markowitz SD Proc Natl Acad Sci U S A; 2006 Aug; 103(32):12098-102. PubMed ID: 16880406 [TBL] [Abstract][Full Text] [Related]
7. Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs). Tai HH; Chi X; Tong M Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):37-40. PubMed ID: 21763448 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-21 induces loss of 15-hydroxyprostaglandin dehydrogenase in early gastric tubular adenocarcinoma. Park YS; Lee JH; Jung DB; Kim HB; Jung JH; Pak S; Ryu YM; Park HJ; Park YY; Jung HY; Myung SJ Sci Rep; 2018 Dec; 8(1):17717. PubMed ID: 30531928 [TBL] [Abstract][Full Text] [Related]
9. A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3 beta as a novel tumor suppressor in lung cancer. Halmos B; Bassères DS; Monti S; D'Aló F; Dayaram T; Ferenczi K; Wouters BJ; Huettner CS; Golub TR; Tenen DG Cancer Res; 2004 Jun; 64(12):4137-47. PubMed ID: 15205324 [TBL] [Abstract][Full Text] [Related]
10. Non-canonical WNT5A signaling up-regulates the expression of the tumor suppressor 15-PGDH and induces differentiation of colon cancer cells. Mehdawi LM; Prasad CP; Ehrnström R; Andersson T; Sjölander A Mol Oncol; 2016 Nov; 10(9):1415-1429. PubMed ID: 27522468 [TBL] [Abstract][Full Text] [Related]
11. The activity of the carbamoyl phosphate synthase 1 promoter in human liver-derived cells is dependent on hepatocyte nuclear factor 3-beta. Chen Z; Tang N; Wang X; Chen Y J Cell Mol Med; 2017 Sep; 21(9):2036-2045. PubMed ID: 28272778 [TBL] [Abstract][Full Text] [Related]
12. NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer. Ding Y; Tong M; Liu S; Moscow JA; Tai HH Carcinogenesis; 2005 Jan; 26(1):65-72. PubMed ID: 15358636 [TBL] [Abstract][Full Text] [Related]
13. The human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene promoter is controlled by Ets and activating protein-1 transcription factors and progesterone. Greenland KJ; Jantke I; Jenatschke S; Bracken KE; Vinson C; Gellersen B Endocrinology; 2000 Feb; 141(2):581-97. PubMed ID: 10650939 [TBL] [Abstract][Full Text] [Related]
14. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma. Castro-Sánchez L; Agra N; Llorente Izquierdo C; Motiño O; Casado M; Boscá L; Martín-Sanz P Int J Biochem Cell Biol; 2013 Nov; 45(11):2501-11. PubMed ID: 23954207 [TBL] [Abstract][Full Text] [Related]
15. 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer. Backlund MG; Mann JR; Holla VR; Buchanan FG; Tai HH; Musiek ES; Milne GL; Katkuri S; DuBois RN J Biol Chem; 2005 Feb; 280(5):3217-23. PubMed ID: 15542609 [TBL] [Abstract][Full Text] [Related]
16. Genomic structure and transcriptional regulation of the human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene. Nandy A; Jenatschke S; Hartung B; Milde-Langosch K; Bamberger AM; Gellersen B J Mol Endocrinol; 2003 Aug; 31(1):105-21. PubMed ID: 12914529 [TBL] [Abstract][Full Text] [Related]
17. Bile acids inhibit NAD+-dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes. Miyaki A; Yang P; Tai HH; Subbaramaiah K; Dannenberg AJ Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G559-66. PubMed ID: 19608733 [TBL] [Abstract][Full Text] [Related]
18. 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer. Thiel A; Ganesan A; Mrena J; Junnila S; Nykänen A; Hemmes A; Tai HH; Monni O; Kokkola A; Haglund C; Petrova TV; Ristimäki A Clin Cancer Res; 2009 Jul; 15(14):4572-80. PubMed ID: 19584167 [TBL] [Abstract][Full Text] [Related]
19. β-catenin represses expression of the tumour suppressor 15-prostaglandin dehydrogenase in the normal intestinal epithelium and colorectal tumour cells. Smartt HJ; Greenhough A; Ordóñez-Morán P; Talero E; Cherry CA; Wallam CA; Parry L; Al Kharusi M; Roberts HR; Mariadason JM; Clarke AR; Huelsken J; Williams AC; Paraskeva C Gut; 2012 Sep; 61(9):1306-14. PubMed ID: 22082586 [TBL] [Abstract][Full Text] [Related]
20. A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells. Mehdawi LM; Satapathy SR; Gustafsson A; Lundholm K; Alvarado-Kristensson M; Sjölander A Oncotarget; 2017 May; 8(21):35033-35047. PubMed ID: 28402256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]